References
- American College of Obstetricians and Gynecologists Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists. Obstet Gynecol. 2013;122:1122.
- International Federation of Gynecology and Obstetrics. The FIGO textbook of pregnancy hypertension an evidence-based guide to monitoring, prevention and management. The Global Library of Women’s Medicine; 2016. WWW document. http://www.glowm.com/pdf/NEW-Pregnancy_Hypertension-Final.pdf#page=81.
- Staff A, Redman C. Making sense of pre-eclampsia: two placental causes of pre-eclampsia? J Reprod Immunol. 2016;115:41. doi:https://doi.org/10.1016/j.jri.2016.04.125
- Parham P. NK cells and trophoblasts: partners in pregnancy. J Exp Med. 2004;200:951–955. doi:https://doi.org/10.1084/jem.20041783.
- Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66:497–506. doi:https://doi.org/10.1097/OGX.0b013e3182331028.
- Alıcı Davutoğlu E, Akkaya Firat A, Ozel A, Yılmaz N, Uzun I, Temel Yuksel I, Madazlı R Evaluation of maternal plasma hypoxia inducible factor-1α, progranulin and syndecan-1 levels in pregnancies with early- and late-onset preeclampsia. J Matern Fetal Neonatal Med. 2017;31(15):1976–1982. doi:https://doi.org/10.1080/14767058.2017.1333098
- Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Celik T, Iyisoy A. Endocan: a novel inflammatory indicator in cardiovascular disease? Atherosclerosis. 2015; 243:339–343. doi:https://doi.org/10.1016/j.atherosclerosis.2015.09.030.
- Yuksel MA, Tuten A, Oncul M, Acikgoz AS, Temel Yuksel I, Toprak MS, Ekmekci H, Balci Ekmekci O, Madazli R. Plasma endocan concentration in women with preeclampsia. Arch Gynecol Obstet. 2015;292:69–73. doi:https://doi.org/10.1007/s00404-014-3605-x.
- Hatfield KJ, Lassalle P, Leiva RA, Lindås R, Wendelboe Ø, Bruserud Ø. Plasma levels of endothelium-derived endokan are increased in patients with untreated acute myeloid leukemia. Hematology. 2011;16:351–356. doi:https://doi.org/10.1179/102453311X13127324303434.
- Janke J, Engeli S, Gorzelniak K, et al. Adipose tissue and circulating endothelial cell specific molecule-1 in human obesity. Horm Metab Res. 38:28–33. doi:https://doi.org/10.1055/s-2006-924973.
- Adekola H, Romero R, Chaemsaithong P, Korzeniewski SJ, Dong Z, Yeo L, Hassan SS, Chaiworapongsa T. Endokan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med. 2015;28:1621–1632. doi:https://doi.org/10.3109/14767058.2014.964676.
- Çakmak M, Yılmaz H, Baglar E, et al. Plasma levels of endokan correlate with the presence and severity of preeclampsia. Clin Exp Hypertens. 2016;38:137–142.
- Hentschke MR, Lucas LS, Mistry HD, Pinheiro da Costa BE, Poli-de-Figueiredo CE. Endokan-1 concentrations in maternal and fetal plasma and placentae in in preeclampsia in third trimester of pregnancy. Cytokine. 2015;74:152–156. doi:https://doi.org/10.1016/j.cyto.2015.04.013.
- Chang X, Bian Y, Wu Y, Huang Y, Wang K, Duan T. Endokan of the maternal placenta tissue is increased in preeclampsia. Int J Clin Exp Pathol. 2015;8:14733–14740.
- Wang HZ, Jin Y, Wang P, Han C, Wang ZP, Dong MY. Alteration of plasma endocan in normal pregnancy and preeclampsia. Clin Exp Obstet Gynecol. 2017;44:419–422.
- Schuitemaker J, Woudenberg J, Wijbenga G, Scherjon S, van Pampus M, Faas M. New prognostic marker for the risk to develop early-onset preeclampsia. Pregnancy Hypertens. 2013;3:95–96. doi:https://doi.org/10.1016/j.preghy.2013.04.102.
- Cross S, Buhimschi I, Duzyj C, et al. Endokan (ESM-1): a novel soluble endothelial cell injury marker in preeclampsia (PE) and intrauterine growth restriction (IUGR). Am J Obstet Gynecol. 2013;208(1):S276. doi:https://doi.org/10.1016/j.ajog.2012.10.820
- Ahmed A, Ramma W. Unraveling the theories of preeclampsia: are the protective pathways the new paradigm. Br J Pharmacol. 2015;172:1574–1586. doi:https://doi.org/10.1111/bph.12977.
- Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R, Rogler A, Stohr R, Hartmann A, Provenzano M, et al. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res. 2013;73:1097–1106. doi:https://doi.org/10.1158/0008-5472.CAN-12-1855.